N-Nitroso Eltrombopag Impurity 3
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

N-Nitroso Eltrombopag Impurity 3

● Failure Report (NAP Test) Available

Catalogue No.:VE0026493
CAS No.:N/A
Mol. Formula:C13H11N3O4
Mol. Weight:273.24 g/mol

Additional information on

Parent drug

Eltrombopag

IUPAC Name

2`-Hydroxy-3`-(1-nitrosohydrazinyl)-[1,1`-biphenyl]-3-carboxylic acid

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=C(C1=CC(C2=CC=CC(N(N=O)N)=C2O)=CC=C1)O

InChI

InChI=1S/C13H11N3O4/c14-16(15-20)11-6-2-5-10(12(11)17)8-3-1-4-9(7-8)13(18)19/h1-7,17H,14H2,(H,18,19)

Description

N-Nitroso Eltrombopag Impurity 3 is a nitrosamine-class degradation product associated with eltrombopag that requires rigorous identification and control due to potential genotoxicity. This impurity is characterized by its N-nitroso functionality, molecular mass and chromatographic behavior, and is routinely monitored using sensitive LC-MS/MS and high-resolution mass spectrometry methods for trace-level quantitation. Structural confirmation relies on accurate mass, fragmentation pattern and comparison to reference standards. Regulatory frameworks and ICH M7 guidance drive strict specification limits and risk-based mitigation strategies. Suppliers provide impurity profiles, analytical data and stability information to support quality, safety and regulatory submissions.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url